Novozymes A/S (NVZMY)

Market Cap	27.56B -5.5%
Revenue (ttm)	4.84B +3.5%
Net Income	688.00M +30.1%
EPS	1.47 -19.1%
Shares Out	n/a
PE Ratio	40.06
Forward PE	23.66
Dividend	0.59 (0.99%)
Ex-Dividend Date	Mar 25, 2026

Volume	43,713
Average Volume	45,729
Open	59.43
Previous Close	59.15
Day's Range	58.84 - 59.72
52-Week Range	49.90 - 75.99
Beta	0.63
RSI	47.72
Earnings Date	May 5, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; e...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1925
• Employees: 11,263
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVZMY

Financial Performance

In 2025, Novozymes's revenue was 4.16 billion, an increase of 8.45% compared to the previous year's 3.83 billion. Earnings were 583.60 million, an increase of 90.84%.

Financial numbers in EUR